Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Minimal Risks With SBRT in Stage I NSCLC
TOPLINE: Patients with stage I non–small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) have a low rate of acute toxicities and 90-day mortality, according to a recent study evaluating real-world patient outcomes. METHODOLOGY: SBRT is generally considered…
English